INS and Impaired glucose tolerance: Furthermore, the pioglitazone treatment lowered concentrations of fasting glucose, insulin, and HbA1c in type 2 diabetic patients56, while another TZD, rosiglitazone, improved overall glucose tolerance and increased insulin sensitivity in patients with impaired glucose tolerance and type 2 diabetes57.